Crossref
MUTATED TP53 PREDICTS PERITONEAL FAILURE AFTER CURATIVE-INTENT SURGERY FOR PANCREATIC CANCER
HPB · 2026 · 28 · S32
DOI: 10.1016/j.hpb.2026.04.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von S. Patel und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, S., McPhaul, T., Burkhart, R., Cameron, J., Molin, M. D., Lafaro, K., Shubert, C., He, J., & Burns, W. (2026). MUTATED TP53 PREDICTS PERITONEAL FAILURE AFTER CURATIVE-INTENT SURGERY FOR PANCREATIC CANCER. HPB, 28, S32. https://doi.org/10.1016/j.hpb.2026.04.052
Vancouver
Patel S, McPhaul T, Burkhart R, Cameron J, Molin MD, Lafaro K, et al. MUTATED TP53 PREDICTS PERITONEAL FAILURE AFTER CURATIVE-INTENT SURGERY FOR PANCREATIC CANCER. HPB. 2026;28:S32. doi:10.1016/j.hpb.2026.04.052
BibTeX
@article{Patel2026,
author = {Patel, S. and McPhaul, T. and Burkhart, R. and Cameron, J. and Molin, M. Dal and Lafaro, K. and Shubert, C. and He, J. and Burns, W.},
title = {MUTATED TP53 PREDICTS PERITONEAL FAILURE AFTER CURATIVE-INTENT SURGERY FOR PANCREATIC CANCER},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S32},
doi = {10.1016/j.hpb.2026.04.052}
}
EUVIMED